Barbora Piskláková
- Spesialingeniør; PhD
- +47 230 70 911
Education
- 2020-2024: PhD in Medical chemistry and Clinical Biochemistry, Palacky University Olomouc, Czechia
- 2018-2020: MSc in Biochemistry, Palacky University Olomouc, Czechia
- 2015-2018: BSc in Biochemistry, Palacky University Olomouc, Czechia
Affiliation
- Metabolomics & Metabolic Molecular Biology Group, Department of Medical Biochemistry, Oslo University Hospital - Rikshospitalet, Norway
Research Summary
Dr. Piskláková's work focuses on LC-MS method development and metabolomic analysis. She is interested in applying global metabolomics for patient diagnosis and integrating metabolomics into clinical practice.
Highlights:
- 2023: 3rd place in the competition for the best work of young authors in the field of spectroscopy in 2023: Rapid and efficient LC-MS/MS diagnosis of inherited metabolic disorders: a semi-automated workflow for the diagnosis of organic acids, acylglycines and acylcarnitines in urine. Jak Marek Marci Spectroscopic Society, Faculty of Chemical Technology, University of Pardubice, Pardubice, Czechia
- 2023: Travel scholarship from the EJPRD programme of the MetbERN network: 3-month internship at Oslo University Hospital, Project Study of the pathobiochemistry of selected inherited metabolic disorders by metabolomics
- 2022: Dean’s Award for significant publication activity in 2021: Evaluation of the Determination of Dabigatran, Rivaroxaban, and Apixaban in Lupus Anticoagulant-Positive Patients, Diagnostics
- Lecturer of the seminar and laboratory practical exercises of the course Medicinal Chemistry (for first-year students of general medicine) – 2 hours every second week (winter semester 2021)
- Supervisor of 4 students for Bachelors and Masters theses
Work Experience
- 2024 October-to date: Spesialingeniør at the Department of Medical Biochemistry, Oslo University Hospital, Norway
- 2020 September-2024 September: Assistant and junior researcher at the Faculty of Medicine and Dentistry, Palacký University Olomouc, Czechia
- 2023 January-2024 September: Researcher at the Laboratory of Inherited Metabolic disorders, University Hospital Olomouc, Czechia
- 2023 March-June: Guest researcher (Internship) at Katja Elgstøen’s lab, Department of Medical Biochemsitry, Oslo University Hospital, Norway
Links
NB: Visit our NEWS PAGE for the latest updates and our Gallery for group social events!
Publications 2025
The kinetics of uracil-N-glycosylase distribution inside replication foci
Sci Rep, 15 (1), 3026
DOI 10.1038/s41598-024-84408-x, PubMed 39849039
Publications 2024
Wide metabolite coverage LC-MS/MS assay for the diagnosis of inherited metabolic disorders in urine
Talanta, 271, 125699
DOI 10.1016/j.talanta.2024.125699, PubMed 38262132
Publications 2023
Clinical lipidomics in the era of the big data
Clin Chem Lab Med, 61 (4), 587-598
DOI 10.1515/cclm-2022-1105, PubMed 36592414
A new technique for the analysis of metabolic pathways of cytidine analogues and cytidine deaminase activities in cells
Sci Rep, 13 (1), 20530
DOI 10.1038/s41598-023-47792-4, PubMed 37993628
Rapid and efficient LC-MS/MS diagnosis of inherited metabolic disorders: a semi-automated workflow for analysis of organic acids, acylglycines, and acylcarnitines in urine
Clin Chem Lab Med, 61 (11), 2017-2027
DOI 10.1515/cclm-2023-0084, PubMed 37207286
Publications 2022
Determination of Thrombogenicity Levels of Various Antiphospholipid Antibodies by a Modified Thrombin Generation Assay in Patients with Suspected Antiphospholipid Syndrome
Int J Mol Sci, 23 (16)
DOI 10.3390/ijms23168973, PubMed 36012233
Publications 2021
Evaluation of the Determination of Dabigatran, Rivaroxaban, and Apixaban in Lupus Anticoagulant-Positive Patients
Diagnostics (Basel), 11 (11)
DOI 10.3390/diagnostics11112027, PubMed 34829374